Drugs that block enzymes called tyrosine kinases are among the most effective targeted therapies for cancer. However, they ...

Some cancer treatments fail not because the drugs were ineffective, but because tumours design a network to evade them.

A new study conducted by researchers from the University of Potsdam and the University of Cologne has deciphered the ...

Today's nearly $70 billion U.S. biofuels economy is powered by two technology toolboxes. Biochemical technologies—used to produce around 17 billion gallons of ethanol annually—leverage microorganisms ...

Rheumatoid arthritis is a chronic autoimmune disease that affects millions of people worldwide. This disease prompts the ...

How does the gut cause Multiple Sclerosis? New research identifies the MHC II protein in intestinal epithelial cells as the trigger for MS-related neuroinflammation. Discover how gut-primed T cells ...

Gut microbiome changes may drive age-related memory loss via inflammation and disrupted brain signaling, but interventions in mice show this process can be reversed.

As inflamed regions of the gut form scar tissue, the space within the gut lumen becomes smaller and more restricted, leading ...

A light micrograph of a mouse embryo. RIKEN researchers have created synthetic molecular pathways that illuminate embryonic development. © ...

Scientists have discovered a previously unknown pathway that allows toxic proteins linked to Huntington’s disease to spread ...

The article, titled "Emerging roles of immune cell-derived neurotransmitters in immunity and disease," published on March 17, ...

Parent Project Muscular Dystrophy (PPMD), the leading U.S. non-profit driving Duchenne and Becker muscular dystrophy care, research, and advocacy efforts, and Secretome Therapeutics (Secretome) are ...